These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11766996)

  • 21. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.
    Iványi Z; Hauser B; Pittner A; Asfar P; Vassilev D; Nalos M; Altherr J; Brückner UB; Szabó C; Radermacher P; Fröba G
    Shock; 2003 May; 19(5):415-21. PubMed ID: 12744483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.
    Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY
    Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
    Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis.
    Mao X; Wang S; Pan Y; He B; Chen J; Jiang H; Zeng Q; Xu X
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):274-82. PubMed ID: 19513971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage].
    Fan HB; Wang YN; Geng DQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation.
    Mazzon E; Serraino I; Li JH; Dugo L; Caputi AP; Zhang J; Cuzzocrea S
    Eur J Pharmacol; 2001 Mar; 415(1):85-94. PubMed ID: 11245856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock.
    Veres B; Gallyas F; Varbiro G; Berente Z; Osz E; Szekeres G; Szabo C; Sumegi B
    Biochem Pharmacol; 2003 Apr; 65(8):1373-82. PubMed ID: 12694878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
    Geraets L; Haegens A; Weseler AR; Brauers K; Vernooy JH; Wouters EF; Bast A; Hageman GJ
    Eur J Pharmacol; 2010 Mar; 629(1-3):132-9. PubMed ID: 19962977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
    Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z
    J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
    Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
    Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis.
    Goldfarb RD; Marton A; Szabó E; Virág L; Salzman AL; Glock D; Akhter I; McCarthy R; Parrillo JE; Szabó C
    Crit Care Med; 2002 May; 30(5):974-80. PubMed ID: 12006790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
    Jiao Y; Li G
    Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
    Lechaftois M; Dreano E; Palmier B; Margaill I; Marchand-Leroux C; Bachelot-Loza C; Lerouet D
    PLoS One; 2014; 9(10):e110776. PubMed ID: 25329809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma.
    Virág L; Bai P; Bak I; Pacher P; Mabley JG; Liaudet L; Bakondi E; Gergely P; Kollai M; Szabó C
    Med Sci Monit; 2004 Mar; 10(3):BR77-83. PubMed ID: 14976461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia.
    Crocker IP; Kenny LC; Thornton WA; Szabo C; Baker PN
    Br J Pharmacol; 2005 Mar; 144(6):772-80. PubMed ID: 15778700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression.
    Geraets L; Moonen HJ; Brauers K; Gottschalk RW; Wouters EF; Bast A; Hageman GJ
    Eur J Pharmacol; 2007 Nov; 573(1-3):241-8. PubMed ID: 17643414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
    J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
    Nangle MR; Cotter MA; Cameron NE
    J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.